Dimitris Voliotis

Dimitris Voliotis

Chief Tech/Sci/R&D Officer at RADIOPHARM THERANOSTICS LIMITED
63 year
Health Technology
Consumer Services
Health Services

Profile

Dimitris Voliotis currently works at Radiopharm Theranostics Ltd., as Chief Medical Officer from 2024.
Dr. Voliotis also formerly worked at CureVac SE, as Chief Development Officer from 2019 to 2020, Eisai, Inc., as Global Head-Clinical Development Oncology from 2016 to 2019, Bayer HealthCare AG, as Vice President & Head-Oncology Group from 2007 to 2014, and Zentalis Pharmaceuticals, Inc., as Senior Vice President-Clinical Development from 2020 to 2023.
Dr. Voliotis received his doctorate degree from Universität zu Köln.

Dimitris Voliotis active positions

CompaniesPositionStart
RADIOPHARM THERANOSTICS LIMITED Chief Tech/Sci/R&D Officer 20/08/2024

Former positions of Dimitris Voliotis

CompaniesPositionEnd
ZENTALIS PHARMACEUTICALS, INC. Corporate Officer/Principal 01/09/2023
Corporate Officer/Principal 01/02/2020
Corporate Officer/Principal 01/01/2019
Corporate Officer/Principal 01/09/2014
See the detail of Dimitris Voliotis's experience

Training of Dimitris Voliotis

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

29

1st degree connections

6

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies6

Health Technology

Health Technology

Health Technology

Consumer Services

Health Technology

Health Services

  1. Stock Market
  2. Insiders
  3. Dimitris Voliotis